Takahashi, H.; Sugimoto, K.; Kamiyama, N.; Sakamaki, K.; Kakegawa, T.; Wada, T.; Tomita, Y.; Abe, M.; Yoshimasu, Y.; Takeuchi, H.;
et al. Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase. Diagnostics 2022, 12, 141.
https://doi.org/10.3390/diagnostics12010141
AMA Style
Takahashi H, Sugimoto K, Kamiyama N, Sakamaki K, Kakegawa T, Wada T, Tomita Y, Abe M, Yoshimasu Y, Takeuchi H,
et al. Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase. Diagnostics. 2022; 12(1):141.
https://doi.org/10.3390/diagnostics12010141
Chicago/Turabian Style
Takahashi, Hiroshi, Katsutoshi Sugimoto, Naohisa Kamiyama, Kentaro Sakamaki, Tatsuya Kakegawa, Takuya Wada, Yusuke Tomita, Masakazu Abe, Yu Yoshimasu, Hirohito Takeuchi,
and et al. 2022. "Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase" Diagnostics 12, no. 1: 141.
https://doi.org/10.3390/diagnostics12010141
APA Style
Takahashi, H., Sugimoto, K., Kamiyama, N., Sakamaki, K., Kakegawa, T., Wada, T., Tomita, Y., Abe, M., Yoshimasu, Y., Takeuchi, H., & Itoi, T.
(2022). Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase. Diagnostics, 12(1), 141.
https://doi.org/10.3390/diagnostics12010141